Angene Chemical
Draw
|
Currency :
Home Products

AG00996Y

1056456-24-6 | 2-Methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole

Chemical structure of 2-Methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole, CAS 1056456-24-6
AG00996Y
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1056456-24-6
Catalog Number AG00996Y(AGN-PC-0WBSPL)
Chemical Name 2-Methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole
IUPAC Name 2-methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole
InChI InChI=1S/C15H19BN2O3/c1-10-17-18-13(19-10)11-6-8-12(9-7-11)16-20-14(2,3)15(4,5)21-16/h6-9H,1-5H3
InChI Key OXEIYXNIHXJZDF-UHFFFAOYSA-N
MDL Number MFCD18384931
Molecular Formula C15H19BN2O3
Molecular Weight 286.1340
SMILES CC=1OC(=NN1)C1=CC=C(C=C1)B1OC(C(O1)(C)C)(C)C
Synonyms
1056456-24-6, 2-methyl-5-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole, 2-Methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole, 2-methyl-5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1,3,4-oxadiazole, 4-(5-METHYL-1,3,4-OXADIAZOL-2-YL)PHENYLBORONIC ACID, PINACOL ESTER, 1056456-25-7, SCHEMBL1458494, DTXSID00694120, OXEIYXNIHXJZDF-UHFFFAOYSA-N, ZXBA000759, ZX-AT014050, MFCD18384931, AKOS015960203, ZINC169810007, OR41016, PB34936, SB19964, KS-000006P8, AK171556, AS-51308, BC000038, CS-0051852, Q-1929, 4-(5-Methyl-1,3,4-oxadiazol-2-yl)phenylboronic acid pinacol ester, (4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl)boronic acid pinacol ester, 4-(5-Methyl-1,3,4-oxadiazol-2-yl)benzeneboronic acid, pinacol ester,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited